TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Carbapenem-based Antibiotics Market – By Type
1.3.2 Global Carbapenem-based Antibiotics Market – By Indication
1.3.3 Global Carbapenem-based Antibiotics Market – By Distribution Channel
1.3.4 Global Carbapenem-based Antibiotics Market – By Geography
2. Carbapenem-based Antibiotics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Carbapenem-based Antibiotics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America– PEST Analysis
4.2.2 Europe– PEST Analysis
4.2.3 Asia Pacific– PEST Analysis
4.2.4 Middle East and Africa– PEST Analysis
4.2.5 South and Central America– PEST Analysis
4.3 Expert Opinions
5. Carbapenem-based Antibiotics Market – Key Market Dynamics
5.1 Drivers
5.1.1 Rising Prevalence of Gram-Negative Bacterial Infections
5.1.2 Increasing Production of Generic Drugs
5.2 Market Restraints
5.2.1 Tedious and Expensive Process of Antibiotic Development
5.3 Market Opportunities
5.3.1 Private and Public Partnerships
5.4 Future Trends
5.4.1 Strategic Advancement for New Antibiotic Identification
5.5 Impact Analysis
6. Carbapenem-based Antibiotics Market – Global Analysis
6.1 Global Carbapenem-based Antibiotics Market Revenue Forecast and Analysis
6.2 Global Carbapenem-based Antibiotics Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Carbapenem-based Antibiotics Market Analysis – By Type
7.1 Overview
7.2 Carbapenem-based Antibiotics Market Revenue Share, by Type (2021 and 2028)
7.3 Meropenem
7.3.1 Overview
7.3.2 Meropenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Doripenem
7.4.1 Overview
7.4.2 Doripenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Imipenem
7.5.1 Overview
7.5.2 Imipenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Tebipenem
7.6.1 Overview
7.6.2 Tebipenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
8. Carbapenem-based Antibiotics Market – By Indication
8.1 Overview
8.2 Carbapenem-based Antibiotics Market, by Indication, 2021 and 2028 (%)
8.3 Bacterial Meningitis
8.3.1 Overview
8.3.2 Bacterial Meningitis: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Acute Pelvic Infections
8.4.1 Overview
8.4.2 Acute Pelvic Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Respiratory Tract Infections
8.5.1 Overview
8.5.2 Respiratory Tract Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Intra-abdominal Infections
8.6.1 Overview
8.6.2 Intra-abdominal Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Urinary Tract Infections
8.7.1 Overview
8.7.2 Urinary Tract Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
9. Carbapenem-based Antibiotics Market – By Distribution Channel
9.1 Overview
9.2 Carbapenem-based Antibiotics Market, by Distribution Channel, 2021 and 2028 (%)
9.3 Retail Pharmacies
9.3.1 Overview
9.3.2 Retail Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Online Pharmacies
9.4.1 Overview
9.4.2 Online Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Hospital Pharmacies
9.5.1 Overview
9.5.2 Hospital Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
10. Carbapenem-based Antibiotics Market – Regional Analysis
10.1 North America: Carbapenem-based Antibiotics Market
10.1.1 Overview
10.1.2 North America: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.1.3 North America: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.1.4 North America: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ Million)
10.1.5 North America: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ Million)
10.1.6 North America: Carbapenem-based Antibiotics Market, by Country, 2021 & 2028 (%)
10.1.6.1 US: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.1.6.1.1 US: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.1.6.1.2 US: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.1.6.1.3 US: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.1.6.1.4 US: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
10.1.6.2 Canada: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.1.6.2.1 Canada: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.1.6.2.2 Canada: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.1.6.2.3 Canada: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.1.6.2.4 Canada: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
10.1.6.3 Mexico: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.1.6.3.1 Mexico: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.1.6.3.2 Mexico: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.1.6.3.3 Mexico: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.1.6.3.4 Mexico: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
10.2 Europe: Carbapenem-based Antibiotics Market
10.2.1 Overview
10.2.2 Europe: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.2.3 Europe: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.2.4 Europe: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ Million)
10.2.5 Europe: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ Million)
10.2.6 Europe: Carbapenem-based Antibiotics Market, by Country, 2021 & 2028 (%)
10.2.6.1 UK: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.2.6.1.1 UK: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.2.6.1.2 UK: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.2.6.1.3 UK: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.2.6.1.4 UK: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
10.2.6.2 Germany: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.2.6.2.1 Germany: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.2.6.2.2 Germany: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.2.6.2.3 Germany: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.2.6.2.4 Germany: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
10.2.6.3 France: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.2.6.3.1 France: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.2.6.3.2 France: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.2.6.3.3 France: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.2.6.3.4 France: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
10.2.6.4 Italy: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.2.6.4.1 Italy: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.2.6.4.2 Italy: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.2.6.4.3 Italy: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.2.6.4.4 Italy: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
10.2.6.5 Spain: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.2.6.5.1 Spain: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.2.6.5.2 Spain: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.2.6.5.3 Spain: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.2.6.5.4 Spain: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
10.2.6.6 Rest of Europe: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.2.6.6.1 Rest of Europe: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.2.6.6.2 Rest of Europe: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.2.6.6.3 Rest of Europe: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.2.6.6.4 Rest of Europe: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
10.3 Asia Pacific: Carbapenem-based Antibiotics Market
10.3.1 Overview
10.3.2 Asia Pacific: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.3.3 Asia Pacific: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.3.4 Asia Pacific: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ Million)
10.3.5 Asia Pacific: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ Million)
10.3.6 Asia Pacific: Carbapenem-based Antibiotics Market, by Country, 2021 & 2028 (%)
10.3.6.1 China: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.3.6.1.1 China: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.3.6.1.2 China: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.3.6.1.3 China: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.3.6.1.4 China: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
10.3.6.2 Japan: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.3.6.2.1 Japan: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.3.6.2.2 Japan: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.3.6.2.3 Japan: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.3.6.2.4 Japan: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
10.3.6.3 India: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.3.6.3.1 India: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.3.6.3.2 India: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.3.6.3.3 India: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.3.6.3.4 India: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
10.3.6.4 Australia: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.3.6.4.1 Australia: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.3.6.4.2 Australia: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.3.6.4.3 Australia: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.3.6.4.4 Australia: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
10.3.6.5 South Korea: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.3.6.5.1 South Korea: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.3.6.5.2 South Korea: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.3.6.5.3 South Korea: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.3.6.5.4 South Korea: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
10.3.6.6 Rest of Asia Pacific: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.3.6.6.1 Rest of Asia Pacific: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.3.6.6.2 Rest of Asia Pacific: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.3.6.6.3 Rest of Asia Pacific: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.3.6.6.4 Rest of Asia Pacific: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
10.4 Middle East and Africa: Carbapenem-based Antibiotics Market
10.4.1 Overview
10.4.2 Middle East and Africa: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.4.3 Middle East and Africa: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.4.4 Middle East and Africa: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ Million)
10.4.5 Middle East and Africa: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ Million)
10.4.6 Middle East and Africa: Carbapenem-based Antibiotics Market, by Country, 2021 & 2028 (%)
10.4.6.1 UAE: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.4.6.1.1 UAE: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.4.6.1.2 UAE: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.4.6.1.3 UAE: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.4.6.1.4 UAE: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
10.4.6.2 Saudi Arabia: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.4.6.2.1 Saudi Arabia: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.4.6.2.2 Saudi Arabia: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.4.6.2.3 Saudi Arabia: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.4.6.2.4 Saudi Arabia: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
10.4.6.3 South Africa: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.4.6.3.1 South Africa: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.4.6.3.2 South Africa: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.4.6.3.3 South Africa: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.4.6.3.4 South Africa: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
10.4.6.4 Rest of Middle East and Africa: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.4.6.4.1 Rest of Middle East and Africa: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.4.6.4.2 Rest of Middle East and Africa: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.4.6.4.3 Rest of Middle East and Africa: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.4.6.4.4 Rest of Middle East and Africa: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
10.5 South and Central America: Carbapenem-based Antibiotics Market
10.5.1 Overview
10.5.2 South and Central America: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.5.3 South and Central America: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.5.4 South and Central America: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ Million)
10.5.5 South and Central America: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ Million)
10.5.6 South and Central America: Carbapenem-based Antibiotics Market, by Country, 2021 & 2028 (%)
10.5.6.1 Brazil: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.5.6.1.1 Brazil: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.5.6.1.2 Brazil: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.5.6.1.3 Brazil: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.5.6.1.4 Brazil: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
10.5.6.2 Argentina: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.5.6.2.1 Argentina: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.5.6.2.2 Argentina: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.5.6.2.3 Argentina: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.5.6.2.4 Argentina: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
10.5.6.3 Rest of South and Central America: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.5.6.3.1 Rest of South and Central America: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.5.6.3.2 Rest of South and Central America: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.5.6.3.3 Rest of South and Central America: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.5.6.3.4 Rest of South and Central America: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
11. Impact of COVID-19 Pandemic on Global Carbapenem-based Antibiotics Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic
12. Carbapenem-based Antibiotics Market–Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Carbapenem-based Antibiotics Market (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. COMPANY PROFILES
13.1 ACS Dobfar S.p.A
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Iterum Therapeutics plc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 DAEWOONG PHARMACEUTICAL CO.,LTD
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Aurobindo Pharma Ltd
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Gland Pharma Limited
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Merck & Co., Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Sumitomo Dainippon Pharma Co., Ltd.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Savior Lifetec
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Pfizer Inc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Spero Therapeutics
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES.
Table 1. North America: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 2. North America: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 3. North America: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 4. US: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 5. US: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 6. US: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 7. Canada: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 8. Canada: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 9. Canada: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 10. Mexico: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 11. Mexico: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 12. Mexico: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 13. Europe: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 14. Europe: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 15. Europe: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 16. UK: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 17. UK: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 18. UK: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 19. Germany: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 20. Germany: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 21. Germany: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 22. France: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 23. France: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 24. France: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 25. Italy: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 26. Italy: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 27. Italy: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 28. Spain: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 29. Spain: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 30. Spain: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 31. Rest of Europe: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 32. Rest of Europe: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 33. Rest of Europe: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 34. Asia Pacific: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 35. Asia Pacific: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 36. Asia Pacific: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 37. China: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 38. China: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 39. China: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 40. Japan: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 41. Japan: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 42. Japan: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 43. India: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 44. India: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 45. India: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 46. Australia: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 47. Australia: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 48. Australia: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 49. South Korea: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 50. South Korea: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 51. South Korea: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 52. Rest of Asia Pacific: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 53. Rest of Asia Pacific: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 54. Rest of Asia Pacific: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 55. Middle East and Africa: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 56. Middle East and Africa: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 57. Middle East and Africa: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 58. UAE: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 59. UAE: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 60. UAE: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 61. Saudi Arabia: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 62. Saudi Arabia: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 63. Saudi Arabia: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 64. South Africa: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 65. South Africa: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 66. South Africa: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 67. Rest of Middle East and Africa: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 68. Rest of Middle East and Africa: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 69. Rest of Middle East and Africa: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 70. South and Central America: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 71. South and Central America: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 72. South and Central America: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 73. Brazil: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 74. Brazil: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 75. Brazil: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 76. Argentina: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 77. Argentina: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 78. Argentina: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 79. Rest of South and Central America: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 80. Rest of South and Central America: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 81. Rest of South and Central America: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 82. Organic Developments in the Carbapenem-based Antibiotics Market
Table 83. Inorganic Developments in the Carbapenem-based Antibiotics Market
Table 84. Glossary of Terms, Carbapenem-based Antibiotics Market